Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
About this item
Full title
Author / Creator
Publisher
Milan: Springer Milan
Journal title
Language
English
Formats
Publication information
Publisher
Milan: Springer Milan
Subjects
More information
Scope and Contents
Contents
Borderline resectable pancreatic cancer is now recognized as a distinct clinical entity. In these cases, neoadjuvant treatment could maximize the potential for an R0 resection and avoid R1/R2 resections. In fact, by analyzing, the current literature is evident that approximately one-third of initially borderline resectable pancreatic tumors may und...
Alternative Titles
Full title
Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1841127049
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1841127049
Other Identifiers
ISSN
2038-131X
E-ISSN
2038-3312
DOI
10.1007/s13304-016-0392-x
